Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1989 3
1993 1
1994 3
1997 2
1998 3
2000 2
2002 1
2004 2
2005 2
2006 7
2007 4
2008 4
2009 8
2010 6
2011 9
2012 9
2013 10
2014 3
2015 3
2016 2
2017 3
2018 3
2019 3
2020 3
2021 4
2022 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
A validation study of potential prognostic DNA methylation biomarkers in patients with acute myeloid leukemia using a custom DNA methylation sequencing panel.
Šestáková Š, Cerovská E, Šálek C, Kundrát D, Ježíšková I, Folta A, Mayer J, Ráčil Z, Cetkovský P, Remešová H. Šestáková Š, et al. Among authors: cetkovsky p. Clin Epigenetics. 2022 Feb 11;14(1):22. doi: 10.1186/s13148-022-01242-6. Clin Epigenetics. 2022. PMID: 35148810 Free PMC article.
Single and multiple point NRAS mutations in acute myeloid leukemia: a study of 327 well molecularly characterized patients.
Durinikova A, Folta A, Pardy F, Svaton J, Drncova M, Weinbergerova B, Cetkovsky P, Racil Z, Jindra P, Szotkowski T, Zak P, Mayer J, Jeziskova I. Durinikova A, et al. Among authors: cetkovsky p. Leuk Lymphoma. 2022 Dec;63(13):3237-3240. doi: 10.1080/10428194.2022.2116931. Epub 2022 Sep 1. Leuk Lymphoma. 2022. PMID: 36047997 No abstract available.
Low levels of minimal residual disease after induction chemotherapy for BCR-ABL1-negative acute lymphoblastic leukaemia in adults are clinically relevant.
Šálek C, Folber F, Froňková E, Pecherková P, Jelínková H, Hrabovský Š, Horáček JM, Cetkovský P, Mayer J, Trka J, Doubek M; Czech Leukemia Study Group - for Life (CELL). Šálek C, et al. Among authors: cetkovsky p. Br J Haematol. 2022 Feb;196(3):706-710. doi: 10.1111/bjh.17966. Epub 2021 Nov 23. Br J Haematol. 2022. PMID: 34816424
Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy.
Racil Z, Koritakova E, Sacha T, Klamova H, Belohlavkova P, Faber E, Rea D, Malaskova L, Prochazkova J, Zackova D, Voglova J, Wącław J, Cetkovsky P, Zak P, Mayer J. Racil Z, et al. Among authors: cetkovsky p. Am J Hematol. 2018 Oct;93(10):E342-E345. doi: 10.1002/ajh.25232. Epub 2018 Aug 31. Am J Hematol. 2018. PMID: 30054949 Free article. No abstract available.
High-dose cytosine arabinoside-induced cutaneous reactions.
Cetkovská P, Pizinger K, Cetkovský P. Cetkovská P, et al. Among authors: cetkovsky p. J Eur Acad Dermatol Venereol. 2002 Sep;16(5):481-5. doi: 10.1046/j.1468-3083.2002.00395.x. J Eur Acad Dermatol Venereol. 2002. PMID: 12428842
Successful early use of anti-SARS-CoV-2 monoclonal neutralizing antibodies in SARS-CoV-2 infected hematological patients - A Czech multicenter experience.
Weinbergerová B, Demel I, Víšek B, Válka J, Čerňan M, Jindra P, Novák J, Stejskal L, Kovácsová F, Kabut T, Szotkowski T, Hájek R, Žák P, Cetkovský P, Král Z, Mayer J. Weinbergerová B, et al. Among authors: cetkovsky p. Hematol Oncol. 2022 Apr;40(2):280-286. doi: 10.1002/hon.2974. Epub 2022 Feb 17. Hematol Oncol. 2022. PMID: 35120267 Free PMC article.
93 results